The Last 30 Days: How Oncologists’ Choices Affect End-of-Life Cancer CareAugust 2, 2024Genitourinary CancerBreast CancerLung CancerMelanomaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMixed Topics
Ancient Viruses in Our DNA Hold Clues to Cancer TreatmentAugust 2, 2024Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Should Cancer Trial Eligibility Become More Inclusive?July 10, 2024Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Urticaria Linked to Higher Cancer Risk, Study FindsJuly 3, 2024MelanomaOncologyAMLMixed TopicsMultiple MyelomaBreast CancerGenitourinary Cancer
One Patient Changed This Oncologist’s View of Hope. Here’s How.June 19, 2024Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Obesity and Cancer: Untangling a Complex WebMay 28, 2024Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMixed Topics
Urine Tests Could Be ‘Enormous Step’ in Diagnosing CancerMay 22, 2024Breast CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerMelanomaLymphoma & Plasma Cell DisordersOncology
New mRNA Vaccines in Development for Cancer and InfectionsMay 10, 2024Breast CancerHead & Neck/Thyroid CancersGenitourinary CancerLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Can a Risk Score Predict Kidney Injury After Cisplatin?May 10, 2024Genitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanomaMixed Topics
Do Patients Benefit from Cancer Trial Participation?May 8, 2024MelanomaLung CancerBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
The Long, Controversial Search for a ‘Cancer Microbiome’May 6, 2024Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersLung CancerMelanoma
Few Cancer Survivors Meet ACS Nutrition, Exercise GuidelinesApril 26, 2024Genitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanomaAML
Most Targeted Cancer Drugs Lack Substantial Clinical BenefitApril 17, 2024Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
No Routine Cancer Screening Option? New MCED Tests May HelpApril 15, 2024MelanomaLymphoma & Plasma Cell DisordersLung CancerLeukemia, Myelodysplasia, TransplantationHead & Neck/Thyroid CancersGenitourinary CancerBreast Cancer
Oncologists Voice Ethical Concerns Over AI in Cancer CareApril 12, 2024Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationMelanomaLymphoma & Plasma Cell DisordersLung Cancer
